サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1711121

ファーマコビジランス・アウトソーシングの世界市場レポート 2025年

Pharmacovigilance Outsourcing Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ファーマコビジランス・アウトソーシングの世界市場レポート 2025年
出版日: 2025年04月03日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ファーマコビジランス・アウトソーシングの市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は17.3%で137億3,000万米ドルに成長します。予測期間の成長は、生物製剤とバイオシミラーの成長、個別化医療への注目の高まり、実臨床エビデンスへの需要の高まり、薬剤安全性プロファイルの複雑化、患者中心のケアの重視の高まりに起因しています。予測期間における主な動向としては、ビッグデータ分析の利用の増加、パートナーシップとコラボレーションの増加、クラウドベースのファーマコビジランスソリューションの採用、ファーマコビジランスとデジタルヘルスプラットフォームの統合、遺伝子治療に特化したファーマコビジランスサービスの開発などが挙げられます。

ファーマコビジランス・アウトソーシング市場の成長は、臨床試験の増加によって牽引されると予測されます。臨床試験とは、新しい治療法、医薬品、医療機器の安全性、有効性、潜在的な副作用を評価するための調査です。臨床試験の増加は、精密医療の重視、慢性疾患の蔓延、規制当局の支援、研究の世界化などの要因によって促進されています。臨床試験におけるファーマコビジランスのアウトソーシングは、専門的な専門知識とリソースを活用することで医薬品の安全性監視を改善し、規制遵守を確保するとともに効率を高める。例えば、2023年11月、英国製薬工業協会（Association of the British Pharmaceutical Industry）は、英国における業界主催の臨床試験件数が4.3%微増し、2021年の394件から2022年には411件に増加すると報告しました。このように、臨床試験数の増加がファーマコビジランス・アウトソーシング市場の拡大を牽引しています。

ファーマコビジランス・アウトソーシング市場の主なプレーヤーは、ファーマコビジランス症例処理と安全性データ管理を最適化するために、クラウドベースのデータレイクプラットフォームなどの革新的なソリューションの開発に注力しています。これらのプラットフォームは、臨床研究レジストリを強化し、規制コンプライアンスを確保するのに役立ちます。クラウドベースのデータレイク・プラットフォームは、大量の生データを必要な時までネイティブフォーマットで保存・管理する一元化されたリポジトリです。例えば、2023年12月、米国を拠点とするバイオテクノロジーおよび実験機器企業であるThermo Fisher Scientific Inc.は、CorEvidenceを発表しました。このプラットフォームは、ファーマコビジランス症例処理を合理化し、複数のデータソースを管理することで、臨床研究登録を改善するように設計されています。有害事象のコード化、分類、報告を最適化し、スケーラブルでコンプライアンスに対応した監査可能な安全性管理を提供するとともに、様々な治療領域における長期的な承認後安全性試験をサポートします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界ファーマコビジランス・アウトソーシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のファーマコビジランス・アウトソーシング市場：成長率分析
  • 世界のファーマコビジランス・アウトソーシング市場の実績：規模と成長, 2019-2024
  • 世界のファーマコビジランス・アウトソーシング市場の予測：規模と成長, 2024-2029, 2034F
  • 世界ファーマコビジランス・アウトソーシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のファーマコビジランス・アウトソーシング市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 薬物有害反応捕捉（ADR）
  • ケース処理
  • 報告と提出
  • レポートの公開
  • 品質チェック
  • リスク管理
  • ナレッジマネジメント
  • アーキテクチャを実現する
  • 世界のファーマコビジランス・アウトソーシング市場サービスプロバイダー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 契約調査機関
  • ビジネス処理アウトソーシング
  • 世界のファーマコビジランス・アウトソーシング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 製薬業界
  • 調査機関
  • その他エンドユーザー
  • 世界のファーマコビジランス・アウトソーシング市場、薬物有害反応捕捉（ADR）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 自動ADRレポートツール
  • 手動ADRレポートソリューション
  • ADRデータマイニングソフトウェア
  • 世界のファーマコビジランス・アウトソーシング市場、ケース処理の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ケース受付およびトリアージサービス
  • 医療レビューおよび評価サービス
  • データ入力および管理サービス
  • 世界のファーマコビジランス・アウトソーシング市場、報告と提出の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 規制報告サービス
  • 保健当局への提出
  • コンプライアンス追跡サービス
  • 世界のファーマコビジランス・アウトソーシング市場レポート発行のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 臨床研究報告書の出版
  • 安全性更新レポートの公開
  • 最終調査報告書の出版
  • 世界のファーマコビジランス・アウトソーシング市場品質チェックの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 品質保証サービス
  • 監査および検査サービス
  • コンプライアンス監視サービス
  • 世界のファーマコビジランス・アウトソーシング市場、リスク管理のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • リスク評価サービス
  • リスク最小化戦略
  • ベネフィット・リスク評価サービス
  • 世界のファーマコビジランス・アウトソーシング市場ナレッジマネジメントのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
  • データ管理ソリューション
  • 医薬品安全性監視データベース管理
  • 知識共有プラットフォーム
  • 世界のファーマコビジランス・アウトソーシング市場、イネーブルメントアーキテクチャのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ITインフラストラクチャソリューション
  • データ統合サービス
  • テクノロジープラットフォームサポート

第7章 地域別・国別分析

  • 世界のファーマコビジランス・アウトソーシング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のファーマコビジランス・アウトソーシング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ファーマコビジランス・アウトソーシング市場：競合情勢
  • ファーマコビジランス・アウトソーシング市場：企業プロファイル
    • ACCENTURE PLC Overview, Products and Services, Strategy and Financial Analysis
    • International Business Machines Corporation（IBM）Overview, Products and Services, Strategy and Financial Analysis
    • Tata Consultancy Services Overview, Products and Services, Strategy and Financial Analysis
    • Capgemini SE Overview, Products and Services, Strategy and Financial Analysis
    • Cognizant Technology Solutions Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • IQVIA Holdings Inc.
  • Laboratory Corporation of America Holdings（Labcorp）
  • Wipro Limited
  • ICON PLC
  • Syneos Health
  • Genpact limited
  • Parexel International Corp
  • Veeva Systems Inc.
  • Medpace Holdings Inc.
  • ProPharma Group
  • Pharmalex GmbH
  • PrimeVigilance Ltd.
  • Global Pharma Tek
  • Veristat LLC
  • United BioSource LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • ファーマコビジランス・アウトソーシング市場2029：新たな機会を提供する国
  • ファーマコビジランス・アウトソーシング市場2029：新たな機会を提供するセグメント
  • ファーマコビジランス・アウトソーシング市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r32146

Pharmacovigilance outsourcing involves hiring external service providers to manage and perform pharmacovigilance activities for pharmaceutical companies. These activities encompass detecting, assessing, understanding, and preventing adverse effects or other drug-related issues.

The primary types of pharmacovigilance outsourcing include adverse drug reaction capture (ADR), case processing, reporting and submission, report publishing, quality checks, risk management, knowledge management, and enabling architecture. ADR capture involves identifying, documenting, and analyzing harmful or unintended reactions to medications to ensure drug safety and enhance patient care. These services are typically offered by contract research organizations and business process outsourcing companies. The main users of these outsourced services include the pharmaceutical industry, research organizations, and other stakeholders.

The pharmacovigilance outsourcing market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance outsourcing market statistics, including pharmacovigilance outsourcing industry global market size, regional shares, competitors with a pharmacovigilance outsourcing market share, detailed pharmacovigilance outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance outsourcing industry. This pharmacovigilance outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacovigilance outsourcing market size has grown rapidly in recent years. It will grow from $6.16 $ billion in 2024 to $7.24 $ billion in 2025 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to increasing drug development activities, stringent regulatory requirements, a rising incidence of adverse drug reactions, growing patient safety concerns, and increasing outsourcing by small and mid-sized companies.

The pharmacovigilance outsourcing market size is expected to see rapid growth in the next few years. It will grow to $13.73 $ billion in 2029 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to the growth of biologics and biosimilars, the rising focus on personalized medicine, the rising demand for real-world evidence, the increasing complexity of drug safety profiles, and the growing emphasis on patient-centric care. Major trends in the forecast period include the increasing use of big data analytics, a rise in partnerships and collaborations, the adoption of cloud-based pharmacovigilance solutions, the integration of pharmacovigilance with digital health platforms, and the development of specialized pharmacovigilance services for gene therapies.

The growth of the pharmacovigilance outsourcing market is anticipated to be driven by the increasing number of clinical trials. Clinical trials are research studies designed to assess the safety, effectiveness, and potential side effects of new treatments, drugs, or medical devices. The rise in clinical trials is fueled by factors such as the emphasis on precision medicine, the growing prevalence of chronic diseases, regulatory support, and the globalization of research. Outsourcing pharmacovigilance in clinical trials improves drug safety monitoring by utilizing specialized expertise and resources to ensure regulatory compliance and enhance efficiency. For instance, in November 2023, the Association of the British Pharmaceutical Industry reported a slight increase of 4.3% in the number of industry-sponsored clinical trials in the UK, rising from 394 in 2021 to 411 in 2022. Thus, the growing number of clinical trials is driving the expansion of the pharmacovigilance outsourcing market.

Key players in the pharmacovigilance outsourcing market are focusing on developing innovative solutions, such as cloud-based data lake platforms, to optimize pharmacovigilance case processing and safety data management. These platforms help enhance clinical research registries and ensure regulatory compliance. A cloud-based data lake platform is a centralized repository that stores and manages large volumes of raw data in its native format until needed. For example, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology and laboratory equipment company, introduced CorEvidence. This platform is designed to improve clinical research registries by streamlining pharmacovigilance case processing and managing multiple data sources. It optimizes the coding, classification, and reporting of adverse events, offering scalable, compliant, and auditable safety management while supporting long-term post-authorization safety studies across various therapeutic areas.

In November 2023, Permira Advisers LLP, a UK-based investment firm, acquired Ergomed PLC for $0.904 billion. This acquisition is intended to support Ergomed's growth by leveraging Permira's expertise, capital, and global network to enhance Ergomed's commercial, technological, and geographic capabilities and facilitate strategic acquisitions in the contract research organization (CRO) and pharmacovigilance (PV) sectors. Ergomed PLC, based in the UK, offers drug development services, including pharmacovigilance.

Major companies operating in the pharmacovigilance outsourcing market are ACCENTURE PLC, International Business Machines Corporation (IBM), Tata Consultancy Services, Capgemini SE, Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), Wipro Limited, ICON PLC, Syneos Health, Genpact limited, Parexel International Corp, Veeva Systems Inc., Medpace Holdings Inc., ProPharma Group, Pharmalex GmbH, PrimeVigilance Ltd., Global Pharma Tek, Veristat LLC, United BioSource LLC, Lambda Therapeutic Research, ArisGlobal, Biomapas

North America was the largest region in the pharmacovigilance outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacovigilance outsourcing market includes revenues earned by entities by providing services such as pharmacovigilance database management, assessment services, medical information call center services, regulatory consulting and strategy services, pharmacovigilance compliance and auditing, and aggregate reporting and benefit-risk evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacovigilance outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacovigilance outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Adverse Drug Reaction Capture (ADR); Case Processing; Reporting And Submission; Report Publishing; Quality Check; Risk Management; Knowledge Management; Enabling Architecture
  • 2) By Service Provider: Contract Research Organization; Business Processing Outsourcing
  • 3) By End User: Pharmaceutical Industry; Research Organization; Others End Users
  • Subsegments:
  • 1) Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools; Manual ADR Reporting Solutions; ADR Data Mining Software
  • 2) Case Processing: Case Intake and Triage Services; Medical Review and Evaluation Services; Data Entry and Management Services
  • 3) Reporting And Submission: Regulatory Reporting Services; Submission to Health Authorities; Compliance Tracking Services
  • 4) Report Publishing: Clinical Study Report Publishing; Safety Update Report Publishing; Final Study Report Publishing
  • 5) Quality Check: Quality Assurance Services; Audit and Inspection Services; Compliance Monitoring Services
  • 6) Risk Management: Risk Assessment Services; Risk Minimization Strategies; Benefit-Risk Evaluation Services
  • 7) Knowledge Management: Data Management Solutions; Pharmacovigilance Database Management; Knowledge Sharing Platforms
  • 8) Enabling Architecture: IT Infrastructure Solutions; Data Integration Services; Technology Platform Support
  • Companies Mentioned: ACCENTURE PLC; International Business Machines Corporation (IBM); Tata Consultancy Services; Capgemini SE; Cognizant Technology Solutions Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmacovigilance Outsourcing Market Characteristics

3. Pharmacovigilance Outsourcing Market Trends And Strategies

4. Pharmacovigilance Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharmacovigilance Outsourcing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmacovigilance Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmacovigilance Outsourcing Market Growth Rate Analysis
  • 5.4. Global Pharmacovigilance Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmacovigilance Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmacovigilance Outsourcing Total Addressable Market (TAM)

6. Pharmacovigilance Outsourcing Market Segmentation

  • 6.1. Global Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adverse Drug Reaction Capture (ADR)
  • Case Processing
  • Reporting And Submission
  • Report Publishing
  • Quality Check
  • Risk Management
  • Knowledge Management
  • Enabling Architecture
  • 6.2. Global Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Contract Research Organization
  • Business Processing Outsourcing
  • 6.3. Global Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Industry
  • Research Organization
  • Others End Users
  • 6.4. Global Pharmacovigilance Outsourcing Market, Sub-Segmentation Of Adverse Drug Reaction Capture (ADR), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated ADR Reporting Tools
  • Manual ADR Reporting Solutions
  • ADR Data Mining Software
  • 6.5. Global Pharmacovigilance Outsourcing Market, Sub-Segmentation Of Case Processing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Case Intake and Triage Services
  • Medical Review and Evaluation Services
  • Data Entry and Management Services
  • 6.6. Global Pharmacovigilance Outsourcing Market, Sub-Segmentation Of Reporting And Submission, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Regulatory Reporting Services
  • Submission to Health Authorities
  • Compliance Tracking Services
  • 6.7. Global Pharmacovigilance Outsourcing Market, Sub-Segmentation Of Report Publishing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Study Report Publishing
  • Safety Update Report Publishing
  • Final Study Report Publishing
  • 6.8. Global Pharmacovigilance Outsourcing Market, Sub-Segmentation Of Quality Check, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quality Assurance Services
  • Audit and Inspection Services
  • Compliance Monitoring Services
  • 6.9. Global Pharmacovigilance Outsourcing Market, Sub-Segmentation Of Risk Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Risk Assessment Services
  • Risk Minimization Strategies
  • Benefit-Risk Evaluation Services
  • 6.10. Global Pharmacovigilance Outsourcing Market, Sub-Segmentation Of Knowledge Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Management Solutions
  • Pharmacovigilance Database Management
  • Knowledge Sharing Platforms
  • 6.11. Global Pharmacovigilance Outsourcing Market, Sub-Segmentation Of Enabling Architecture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • IT Infrastructure Solutions
  • Data Integration Services
  • Technology Platform Support

7. Pharmacovigilance Outsourcing Market Regional And Country Analysis

  • 7.1. Global Pharmacovigilance Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmacovigilance Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmacovigilance Outsourcing Market

  • 8.1. Asia-Pacific Pharmacovigilance Outsourcing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmacovigilance Outsourcing Market

  • 9.1. China Pharmacovigilance Outsourcing Market Overview
  • 9.2. China Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmacovigilance Outsourcing Market

  • 10.1. India Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmacovigilance Outsourcing Market

  • 11.1. Japan Pharmacovigilance Outsourcing Market Overview
  • 11.2. Japan Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmacovigilance Outsourcing Market

  • 12.1. Australia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmacovigilance Outsourcing Market

  • 13.1. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmacovigilance Outsourcing Market

  • 14.1. South Korea Pharmacovigilance Outsourcing Market Overview
  • 14.2. South Korea Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmacovigilance Outsourcing Market

  • 15.1. Western Europe Pharmacovigilance Outsourcing Market Overview
  • 15.2. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmacovigilance Outsourcing Market

  • 16.1. UK Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmacovigilance Outsourcing Market

  • 17.1. Germany Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmacovigilance Outsourcing Market

  • 18.1. France Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmacovigilance Outsourcing Market

  • 19.1. Italy Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmacovigilance Outsourcing Market

  • 20.1. Spain Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmacovigilance Outsourcing Market

  • 21.1. Eastern Europe Pharmacovigilance Outsourcing Market Overview
  • 21.2. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmacovigilance Outsourcing Market

  • 22.1. Russia Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmacovigilance Outsourcing Market

  • 23.1. North America Pharmacovigilance Outsourcing Market Overview
  • 23.2. North America Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmacovigilance Outsourcing Market

  • 24.1. USA Pharmacovigilance Outsourcing Market Overview
  • 24.2. USA Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmacovigilance Outsourcing Market

  • 25.1. Canada Pharmacovigilance Outsourcing Market Overview
  • 25.2. Canada Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmacovigilance Outsourcing Market

  • 26.1. South America Pharmacovigilance Outsourcing Market Overview
  • 26.2. South America Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmacovigilance Outsourcing Market

  • 27.1. Brazil Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmacovigilance Outsourcing Market

  • 28.1. Middle East Pharmacovigilance Outsourcing Market Overview
  • 28.2. Middle East Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmacovigilance Outsourcing Market

  • 29.1. Africa Pharmacovigilance Outsourcing Market Overview
  • 29.2. Africa Pharmacovigilance Outsourcing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharmacovigilance Outsourcing Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharmacovigilance Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmacovigilance Outsourcing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmacovigilance Outsourcing Market Competitive Landscape
  • 30.2. Pharmacovigilance Outsourcing Market Company Profiles
    • 30.2.1. ACCENTURE PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Tata Consultancy Services Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Capgemini SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cognizant Technology Solutions Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Pharmacovigilance Outsourcing Market Other Major And Innovative Companies

  • 31.1. IQVIA Holdings Inc.
  • 31.2. Laboratory Corporation of America Holdings (Labcorp)
  • 31.3. Wipro Limited
  • 31.4. ICON PLC
  • 31.5. Syneos Health
  • 31.6. Genpact limited
  • 31.7. Parexel International Corp
  • 31.8. Veeva Systems Inc.
  • 31.9. Medpace Holdings Inc.
  • 31.10. ProPharma Group
  • 31.11. Pharmalex GmbH
  • 31.12. PrimeVigilance Ltd.
  • 31.13. Global Pharma Tek
  • 31.14. Veristat LLC
  • 31.15. United BioSource LLC

32. Global Pharmacovigilance Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmacovigilance Outsourcing Market

34. Recent Developments In The Pharmacovigilance Outsourcing Market

35. Pharmacovigilance Outsourcing Market High Potential Countries, Segments and Strategies

  • 35.1 Pharmacovigilance Outsourcing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharmacovigilance Outsourcing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharmacovigilance Outsourcing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer